Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in Functional Dyspepsia
NCT01052896Phase 3Withdrawn
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin in functional dyspepsia (FD). Planned start Mar 2010; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT01052896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052896.